Sign in or create an account to add this stock to your watchlist.
About AquaBounty Technologies (NASDAQ:AQB)
AquaBounty Technologies, Inc., a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts. AquaBounty Technologies, Inc. is a subsidiary of Intrexon Corporation.
Industry, Sector and Symbol
Industry Fishing, hunting & trapping
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AQB
CUSIPN/A
Phone978-648-6000
Debt
Debt-to-Equity Ratio0.11
Current Ratio3.42
Quick Ratio3.36
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$53.28 million
Price / Sales0.71
Cash FlowN/A
Price / CashN/A
Book Value$2.05 per share
Price / Book1.44
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-9,250,000.00
Net MarginsN/A
Return on Equity-43.96%
Return on Assets-35.95%
Miscellaneous
Employees37
Outstanding Shares12,830,000
AquaBounty Technologies (NASDAQ:AQB) Frequently Asked Questions
What is AquaBounty Technologies' stock symbol?
AquaBounty Technologies trades on the NASDAQ under the ticker symbol "AQB."
How were AquaBounty Technologies' earnings last quarter?
AquaBounty Technologies (NASDAQ:AQB) posted its quarterly earnings data on Tuesday, May, 8th. The company reported ($0.21) EPS for the quarter. The business earned $0.02 million during the quarter. View AquaBounty Technologies' Earnings History.
Who are some of AquaBounty Technologies' key competitors?
Some companies that are related to AquaBounty Technologies include XBiotech (XBIT), RedHill Biopharma (RDHL), Spero Therapeutics (SPRO), Emblem (EMC), Pluristem Therapeutics (PSTI), Teligent (TLGT), Intec Pharma (NTEC), Adamis Pharmaceuticals (ADMP), Cannabics Pharmaceuticals (CNBX), Allergy Therapeutics (AGY), Oxford BioDynamics (OBD), BioDelivery Sciences International (BDSI), Verseon (VSN), ContraFect (CFRX) and Second Sight Medical Products (EYES).
Who are AquaBounty Technologies' key executives?
AquaBounty Technologies' management team includes the folowing people:
- Dr. Ronald L. Stotish, CEO, Pres & Exec. Director (Age 69)
- Mr. David A. Frank, CFO & Treasurer (Age 58)
- Mr. Alejandro Rojas, Chief Operating Officer of Aquabounty Farms (Age 56)
- Mr. Christopher H. Martin, Gen. Counsel & Company Sec. (Age 52)
- Mr. Henry C. Clifford, VP of Sales and Marketing (Age 64)
Has AquaBounty Technologies been receiving favorable news coverage?
Media stories about AQB stock have trended positive this week, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. AquaBounty Technologies earned a news impact score of 0.42 on Accern's scale. They also assigned media coverage about the company an impact score of 46.47 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
Who are AquaBounty Technologies' major shareholders?
Which institutional investors are buying AquaBounty Technologies stock?
How do I buy shares of AquaBounty Technologies?
Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is AquaBounty Technologies' stock price today?
One share of AQB stock can currently be purchased for approximately $2.95.
How big of a company is AquaBounty Technologies?
AquaBounty Technologies has a market capitalization of $37.84 million and generates $53.28 million in revenue each year. AquaBounty Technologies employs 37 workers across the globe.
How can I contact AquaBounty Technologies?
AquaBounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at 978-648-6000 or via email at [email protected]
MarketBeat Community Rating for AquaBounty Technologies (AQB)
MarketBeat's community ratings are surveys of what our community members think about AquaBounty Technologies and other stocks. Vote "Outperform" if you believe AQB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AQB will underperform the S&P 500 over the long term. You may vote once every thirty days.
AquaBounty Technologies (NASDAQ:AQB) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 5/27/2016 forward)
AquaBounty Technologies (NASDAQ:AQB) Earnings History and Estimates Chart
AquaBounty Technologies (NASDAQ AQB) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/8/2018 | Q1 2018 | | ($0.21) | | $0.02 million | View | N/A |  |
| 3/8/2018 | Q4 2017 | | ($0.30) | | | View | N/A | |
| 11/2/2017 | Q3 2017 | | ($0.28) | | | View | N/A | |
| 8/4/2017 | Q2 2017 | | ($0.24) | | $0.05 million | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
AquaBounty Technologies (NASDAQ:AQB) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
AquaBounty Technologies (NASDAQ AQB) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 61.78%
AquaBounty Technologies (NASDAQ AQB) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 1/17/2018 | Randal J Kirk | Major Shareholder | Buy | 1,538,461 | $3.25 | $4,999,998.25 | | |
| 1/18/2017 | Randal J Kirk | Major Shareholder | Buy | 2,421,073 | $10.33 | $25,009,684.09 | | |
(Data available from 1/1/2013 forward)
AquaBounty Technologies (NASDAQ AQB) News Headlines
| Source: |
|
AquaBounty Technologies (NASDAQ:AQB) SEC Filings
This page is loading this company's SEC Filings. Please wait...
AquaBounty Technologies (NASDAQ:AQB) Income Statement, Balance Sheet and Cash Flow Statement
AquaBounty Technologies (NASDAQ AQB) Stock Chart for Sunday, May, 27, 2018
Loading chart…
